Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
Activation of PI3K plays a role in pulmonary inflammation. Here, the authors develop a drug inhibitor of PI3K, and show that it inhibits lung inflammation and damage in mouse models of asthma and lung fibrosis.
Enregistré dans:
Auteurs principaux: | Carlo C. Campa, Rangel L. Silva, Jean P. Margaria, Tracey Pirali, Matheus S. Mattos, Lucas R. Kraemer, Diego C. Reis, Giorgio Grosa, Francesca Copperi, Eduardo M. Dalmarco, Roberto C. P. Lima-Júnior, Silvio Aprile, Valentina Sala, Federica Dal Bello, Douglas Silva Prado, Jose Carlos Alves-Filho, Claudio Medana, Geovanni D. Cassali, Gian Cesare Tron, Mauro M. Teixeira, Elisa Ciraolo, Remo C. Russo, Emilio Hirsch |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ffd766e4bb69453a8c45e742f2d6dd75 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Recent Advances in the Synthesis of Polyamine Derivatives and Their Applications
par: Artemiy Nichugovskiy, et autres
Publié: (2021) -
MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis
par: Rachel L. Edwards, et autres
Publié: (2017) -
pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects
par: Eduardo Burgarelli Lages, et autres
Publié: (2021) -
Structure-guided microbial targeting of antistaphylococcal prodrugs
par: Justin J Miller, et autres
Publié: (2021) -
Correction: Structure-guided microbial targeting of antistaphylococcal prodrugs
par: Justin J Miller, et autres
Publié: (2021)